Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036572 (
seizures
)
80,221
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Premature death from
seizures
afflicts gene-targeted mice expressing the Q/R site-unedited glutamate receptor subunit
GluR-B
(Q) of AMPA receptors in central neurons. Early
seizure
-related death has now been circumvented by a genetic switch that restricts
GluR-B
(Q) expression to forebrain principal neurons from postnatal stages onward, prominently in hippocampus and striatum and less so in cortex and amygdala. When switched on, functional receptor incorporation of
GluR-B
(Q) could be demonstrated by imaging evoked AMPA channel-mediated spinous Ca2+ transients in CA1 pyramidal cells. Sustained
GluR-B
(Q) expression in adult mice led to smaller excitatory postsynaptic responses in the CA1 region with unchanged presynaptic fiber excitability. Notably, despite the smaller excitatory response, the CA1 cells exhibited a reduced population spike threshold, which might underlie the spontaneous manifestations of epilepsy, including myocloni and generalized
seizures
with limbic components, observed by synchronous video monitoring and electroencephalographic recordings. No neuropathological symptoms developed when
GluR-B
(Q) expression was restricted to only hippocampal neurons. Our results show that
seizure
susceptibility is triggered by
GluR-B
(Q) expression also in the adult brain and that circuit hyperexcitability is not an immediate consequence of
GluR-B
(Q) but requires yet unknown downstream events, likely to be induced by non-Hebbian plasticity from Ca2+-permeable AMPA channels in principal neurons.
...
PMID:A genetic switch for epilepsy in adult mice. 1554 71
<< Previous
1
2